Cargando…

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia

INTRODUCTION: Lomitapide is a microsomal triglyceride transfer protein inhibitor for patients with homozygous familial hypercholesterolaemia. Due to its mechanism of action, potential hepatic effects of lomitapide are of clinical interest. This study aimed to determine the long‐term hepatic safety o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larrey, Dominique, D'Erasmo, Laura, O'Brien, Sallyann, Arca, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Genetics and Rare Liver Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107656/ https://www.ncbi.nlm.nih.gov/pubmed/36520008 http://dx.doi.org/10.1111/liv.15497

Ejemplares similares

Management of homozygous familial hypercholesterolaemia in two brothers
por: Real, José, et al.
Publicado: (2018)

Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
por: Blom, Dirk J., et al.
Publicado: (2018)

Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study
por: D’Erasmo, Laura, et al.
Publicado: (2022)

Lomitapide treatment in a female with homozygous familial hypercholesterolaemia: a case report
por: Littmann, Karin, et al.
Publicado: (2020)

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
por: Ben-Omran, Tawfeg, et al.
Publicado: (2019)

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
por: Ventura, Paolo, et al.
Publicado: (2021)

Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile
por: Lupo, Maria Giovanna, et al.
Publicado: (2021)

PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases
por: De Re, Valli, et al.
Publicado: (2020)

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2017)

Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
por: Malinová, Vĕra, et al.
Publicado: (2020)

Choledochal malformations in adults in the Netherlands: Results from a nationwide retrospective cohort study
por: de Kleine, Ruben H., et al.
Publicado: (2020)

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2020)

Genetic variant rs72613567 of HSD17B13 gene reduces alcohol‐related liver disease risk in Chinese Han population
por: Chen, Haizhen, et al.
Publicado: (2020)

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
por: Viveiros, André, et al.
Publicado: (2020)

Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection
por: Schaapman, Jelte J., et al.
Publicado: (2020)

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
por: Paternostro, Rafael, et al.
Publicado: (2020)

Prolonged exposure to welding fumes as a novel cause of systemic iron overload
por: Mariani, Raffaella, et al.
Publicado: (2021)

Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis
por: Haisma, Sjoukje‐Marije, et al.
Publicado: (2021)

Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism)
por: Sivunen, Johanna, et al.
Publicado: (2022)

A minority of somatically mutated genes in pre‐existing fatty liver disease have prognostic importance in the development of NAFLD
por: Mann, Jake P., et al.
Publicado: (2022)

Clinical characterization of NTCP deficiency in paediatric patients : A case‐control study based on SLC10A1 genotyping analysis
por: Deng, Li‐Jing, et al.
Publicado: (2021)

Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly
por: Barten, Thijs R. M., et al.
Publicado: (2022)

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
por: Holmer, Magnus, et al.
Publicado: (2022)

Adult male patient with severe intellectual disability caused by a homozygous mutation in the HNMT gene
por: Verhoeven, Willem M A, et al.
Publicado: (2020)

A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting
por: Blom, Dirk J., et al.
Publicado: (2022)

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
por: Stefanutti, Claudia
Publicado: (2020)

Renal tubular dysgenesis: antenatal ultrasound scanning and molecular investigations in a Saudi Arabian family
por: Al-Hamed, Mohamed H., et al.
Publicado: (2016)

Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting
por: Mahzari, Moeber, et al.
Publicado: (2021)

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
por: Cuchel, Marina, et al.
Publicado: (2023)

Persistent severe polyuria after renal transplant
por: Wong, Timothy, et al.
Publicado: (2016)

Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy
por: van der Bilt, Floor E., et al.
Publicado: (2016)

A need for a systematic genetic evaluation of hereditary polyuric patients
por: Bichet, Daniel G., et al.
Publicado: (2016)

Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis
por: Goutaudier, Valentin, et al.
Publicado: (2016)

Adenine phosphoribosyltransferase deficiency in the United Kingdom: two novel mutations and a cross-sectional survey
por: Balasubramaniam, Gowrie S., et al.
Publicado: (2016)

Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex
por: Buj Pradilla, María José, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_53h9sorj28203lmfubup9mnp65